1887

Abstract

In an increasing number of cases the last therapeutic option for treatment of carbapenem-resistant is colistin. As the detection of colistin resistance is problematic and time-consuming, it is desirable to find a rapid and reliable test. The rapid polymyxin NP test developed by Nordmann addresses this problem and has a sensitivity of 99.3  % and a specificity of 95.4  %, as described by the authors.

In this study, we aimed to evaluate the NP test and tested the effect of measuring the absorbance of the test with an enzyme-linked immunosorbent assay (ELISA) reader at 430 nm as an alternative objectified readout. We performed a study with 120 carbapenemase-producing isolates, including 40 colistin-resistant and 23 colistin-susceptible , 4 resistant and 23 susceptible , and 20 susceptible and 10 resistant species, respectively.

Our data showed lower values for sensitivity and specificity than previously, namely only 91  % and 70 %, respectively, due to visual inspection. Furthermore, the results revealed a weakness in the correct detection of colistin-susceptible species. With the measurement of the absorbance we optimized the results to prevent misinterpretations of weak or inconclusive colour changes and enhanced the accuracy and objectivity of the rapid polymyxin NP test results.

We reinforced the rapid polymyxin NP test as a rapid and valuable tool for detecting colistin-resistant isolates, although false-positive results were obtained for several colistin-susceptible spp. By using the optimized method, we were able to increase the sensitivity and specificity values to 94  % and 95  %, respectively.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001030
2019-08-01
2019-08-20
Loading full text...

Full text loading...

References

  1. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791–1798 [CrossRef]
    [Google Scholar]
  2. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–281 [CrossRef]
    [Google Scholar]
  3. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006;6:589–601 [CrossRef]
    [Google Scholar]
  4. Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333–1341 [CrossRef]
    [Google Scholar]
  5. Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 2007;59:786–790 [CrossRef]
    [Google Scholar]
  6. Velkov T, Roberts KD, Nation RL, Thompson PE, Li J. Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics. Future Microbiol 2013;8:711–724 [CrossRef]
    [Google Scholar]
  7. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC et al. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970;72:857–868
    [Google Scholar]
  8. Lim LM, Ly N, Anderson D, Yang JC, Macander L et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 2010;30:1279–1291 [CrossRef]
    [Google Scholar]
  9. Deris ZZ, Akter J, Sivanesan S, Roberts KD, Thompson PE et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot 2014;67:147–151 [CrossRef]
    [Google Scholar]
  10. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005;25:11–25 [CrossRef]
    [Google Scholar]
  11. Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 2017;30:557–596 [CrossRef]
    [Google Scholar]
  12. Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 2014;5:643 [CrossRef]
    [Google Scholar]
  13. Wright MS, Suzuki Y, Jones MB, Marshall SH, Rudin SD et al. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother 2015;59:536–543 [CrossRef]
    [Google Scholar]
  14. Jayol A, Nordmann P, Brink A, Villegas MV, Dubois V et al. High level resistance to colistin mediated by various mutations in the crrB gene among carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2017;61: 24 10 2017 [CrossRef]
    [Google Scholar]
  15. Cheng YH, Lin TL, Lin YT, Wang JT. Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae. Antimicrob Agents Chemother 2016;60:3709–3716 [CrossRef]
    [Google Scholar]
  16. Falagas ME, Rafailidis PI, Matthaiou DK. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 2010;13:132–138 [CrossRef]
    [Google Scholar]
  17. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161–168 [CrossRef]
    [Google Scholar]
  18. Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2 , in Escherichia coli, Belgium, June 2016. Eu rosurveillance 2016;21:30280 [CrossRef]
    [Google Scholar]
  19. Zhi C, Lv L, Yu LF, Doi Y, Liu JH. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016;16:292–293 [CrossRef]
    [Google Scholar]
  20. Humphries RM. Susceptibility testing of the polymyxins: where are we now?. Pharmacotherapy 2015;35:22–27 [CrossRef]
    [Google Scholar]
  21. Tan TY, SY N. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Eur J Clin Microbiol Infect Dis 2007;15:398–402
    [Google Scholar]
  22. Nordmann P, Jayol A, Poirel L. Rapid detection of polymyxin resistance in Enterobacteriaceae. Emerg Infect Dis 2016;22:1038–1043 [CrossRef]
    [Google Scholar]
  23. Committee TE, Testing AS, Changes N, Pseudomonas E. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters 2013; pp3–7
  24. Cannatelli A, Giani T, D’Andrea MM, Di Pilato V, Arena F et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 2014;58:5696–5703 [CrossRef]
    [Google Scholar]
  25. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015;70:75–80 [CrossRef]
    [Google Scholar]
  26. Novović K, Trudić A, Brkić S, Vasiljević Z, Kojić M et al. Molecular epidemiology of colistin-resistant, carbapenemase-producing Klebsiella. 2013;2016
  27. Cannatelli A, D’Andrea MM, Giani T, Di Pilato V, Arena F et al. In Vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 2013;57:5521–5526 [CrossRef]
    [Google Scholar]
  28. Pragasam AK, Shankar C, Veeraraghavan B, Biswas I, Nabarro LEB et al. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae causing bacteremia from India-A first report. Front Microbiol 2016;7:2135 [CrossRef]
    [Google Scholar]
  29. Jayol A, Poirel L, Brink A, Villegas M-V, Yilmaz M et al. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 2014;58:4762–4766 [CrossRef]
    [Google Scholar]
  30. Jayol A, Nordmann P, Lehours P, Poirel L, Dubois V. Comparison of methods for detection of plasmid-mediated and chromosomally encoded colistin resistance in Enterobacteriaceae. Clin Microbiol Infect 2018;24:175–179 [CrossRef]
    [Google Scholar]
  31. Poirel L, Larpin Y, Dobias J, Stephan R, Decousser JW et al. Rapid polymyxin NP test for the detection of polymyxin resistance mediated by the mcr-1/mcr-2 genes. Diagn Microbiol Infect Dis 2018;90:7–10 [CrossRef]
    [Google Scholar]
  32. Simar S, Sibley D, Ashcraft D, Pankey G. Evaluation of the rapid polymyxin NP test for polymyxin B resistance detection using Enterobacter cloacae and Enterobacter aerogenes isolates. J Clin Microbiol 2017;55:3016–3020
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001030
Loading

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error